PrimeRFP SCOUT · Federal Contract Recompete Brief

80ARC022CA007Bioengineer long-lasting 3d neurovascular — Brigham & Womens Hospital Inc

Brigham & Womens Hospital Inc holds $20.7M across 79 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. Competition previously drew 9 offers. Set-aside status: Unrestricted. Recompete timing centers on the Sep 26, 2027 PoP end — agencies typically plan 12–18 months ahead.

Nasa Ames Research Center
Awarding office
Brigham & Womens Hospital Inc
Recipient
Sep 26, 2027
PoP end
$2M
Obligated
$2M
Potential
541715
NAICS
AR11
PSC
Unrestricted
Set-aside
9 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number80ARC022CA007
AgencyNasa Ames Research Center
Awarding officeNasa Ames Research Center
Awarding agencyNational Aeronautics and Space Administration (NASA)
Funding agencyNational Aeronautics and Space Administration (NASA)
IncumbentBrigham & Womens Hospital Inc
CAGE0W3J1
UEIQN6MS4VN7BD1
NAICS541715
PSCAR11
Place of performanceBOSTON MA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitationNNH21ZDA015N
PoP startSep 27, 2022
PoP end (current)Sep 26, 2027
Obligated$2M
Current value$2M
Potential value$2M

Bioengineer Long-Lasting 3D Neurovascular Microphysiological System to Model Chronic Inflammation-Mediated Neurodegener… is a federal Unrestricted award for Nasa Ames Research Center held by Brigham & Womens Hospital Inc. Estimated value $2M ($2M obligated). Current period of performance ends Sep 26, 2027. Last award drew 9 bidders. Place of performance: BOSTON MA. Related solicitation NNH21ZDA015N.

Bioengineer long-lasting 3d neurovascular microphysiological system to model chronic inflammation-mediated neurodegeneration. Latest action is a modification.

Recompete timing

Public
● Expiring in 340 days

Current PoP ends Sep 26, 2027 (340 days remaining). Agencies typically plan 12–18 months ahead — at 11.2 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 80ARC022CA007? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Brigham & Womens Hospital Inc — $20.7M obligated across 79 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($20.7M) · all agencies
Department of Veterans Affairs (VA)$13.0M · 63%Department of Health and Human Services (HHS)$6.9M · 33%National Aeronautics and Space Administration (NASA)$1.5M · 7%Department of Justice (DOJ)$14K · 0%
Open full company profile →

Related awards

Same incumbent
75F40122C00181
CALIBRATING RWE STUDIES IN ONCOLOGY AGAINST RANDOMIZED TRIALS
$4.7M
Jan 29, 2027
75F40122C00154
DESIGN A TWO-STAGE PROCESS FOR USING RWE TO SUPPORT LABELING EXPANSIONS FOR EFFECTIVENESS …
$2.7M
Jun 27, 2027
36C24126N0716
LUNG TRANSPLANT SERVICES
$3.3M
Jun 30, 2027
36C24E26N0226
BIOINFORMATICS RESEARCH SUPPORT
$838K
Sep 13, 2027
36C24E26N0222
BIOINFORMATICS RESEARCH SUPPORT
$740K
Sep 13, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 80ARC022CA007?

80ARC022CA007 (Bioengineer long-lasting 3d neurovascular) is a Nasa Ames Research Center award with a potential value of $2M, currently held by Brigham & Womens Hospital Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 80ARC022CA007?

Nasa Ames Research Center awarded 80ARC022CA007 to Brigham & Womens Hospital Inc (potential $2M).

Who is the incumbent on 80ARC022CA007?

Brigham & Womens Hospital Inc is the incumbent with $20.7M across 79 related awards in SCOUT’s public footprint. The current period of performance ends Sep 26, 2027.

When does Brigham & Womens Hospital Inc’s 80ARC022CA007 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 26, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 80ARC022CA007? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/80ARC022CA007